NASDAQ: ELOXEloxx Pharmaceuticals Inc Stock Ownership - Who owns Eloxx Pharmaceuticals?
Insider buying vs selling
Have Eloxx Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Sumit Aggarwal | President and CEO | 2026-02-28 | 260,946 | $0.15 | $39.14kBuy |
ELOX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ELOX insiders and whales buy or sell their stock.
ELOX Shareholders
What type of owners hold Eloxx Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Paul Edward Klaver | 679.79% | 27,439,581 | $408.30M | Insider |
| Christopher Forbes | 316.05% | 12,757,318 | $189.83M | Insider |
| Ran Nussbaum | 121.40% | 4,900,249 | $72.92M | Insider |
| Pontifax Management III GP 2011 Ltd | 121.40% | 4,900,249 | $72.92M | Insider |
| Tomer Kariv | 121.40% | 4,900,249 | $72.92M | Insider |
| Rajesh B. Parekh | 119.59% | 4,827,129 | $71.83M | Insider |
| Gilad Shabtai | 83.04% | 3,351,770 | $49.87M | Insider |
| Martijn Kleijwegt | 73.17% | 2,953,673 | $43.95M | Insider |
| Harlan Waksal | 69.51% | 2,805,750 | $41.75M | Insider |
| Vaughn Smider | 52.47% | 2,117,940 | $31.51M | Insider |
ELOX vs Biotech Stocks
Eloxx Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.